Bausch Health Companies Inc. (BHC) stock
BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.47+0.05 (+0.59%)
Close on Nov 17, 2026Market cap $3.17BP/E –Yield –
Bausch Health Companies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bausch Health Companies's operating cash flow for the twelve months ending Sep 30, 2026 was $2.21B, up 46.7% year over year. For fiscal 2025 it was $1.40B, down 12.3% from the year before. Over ten years it grew -4.7% a year on average. The highest annual figure on record is $2.31B in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40B | -12.3% |
| FY2024 | Dec 31, 2024 | $1.60B | +54.7% |
| FY2023 | Dec 31, 2023 | $1.03B | – |
| FY2022 | Dec 31, 2022 | -$728.00M | -151.1% |
| FY2021 | Dec 31, 2021 | $1.43B | +28.4% |
| FY2020 | Dec 31, 2020 | $1.11B | -26.0% |
| FY2019 | Dec 31, 2019 | $1.50B | 0.0% |
| FY2018 | Dec 31, 2018 | $1.50B | -34.5% |
| FY2017 | Dec 31, 2017 | $2.29B | +9.7% |
| FY2016 | Dec 31, 2016 | $2.09B | -7.5% |
| FY2015 | Dec 31, 2015 | $2.26B | -2.4% |
| FY2014 | Dec 31, 2014 | $2.31B | +121.9% |
| FY2013 | Dec 31, 2013 | $1.04B | +58.7% |
| FY2012 | Dec 31, 2012 | $656.60M | +2.5% |
| FY2011 | Dec 31, 2011 | $640.47M | +143.3% |
| FY2010 | Dec 31, 2010 | $263.19M | -27.1% |
| FY2009 | Dec 31, 2009 | $360.90M | +76.6% |
| FY2008 | Dec 31, 2008 | $204.33M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $814.00M | +101.0% |
| Q2 FY2026 | Jun 30, 2026 | $670.00M | +131.8% |
| Q1 FY2026 | Mar 31, 2026 | $230.00M | +9.0% |
| Q4 FY2025 | Dec 31, 2025 | $495.00M | -17.6% |
| Q3 FY2025 | Sep 30, 2025 | $405.00M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | $289.00M | -23.9% |
| Q1 FY2025 | Mar 31, 2025 | $211.00M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $601.00M | +54.1% |
| Q3 FY2024 | Sep 30, 2024 | $405.00M | +43.6% |
| Q2 FY2024 | Jun 30, 2024 | $380.00M | +84.5% |
| Q1 FY2024 | Mar 31, 2024 | $211.00M | +37.0% |
| Q4 FY2023 | Dec 31, 2023 | $390.00M | -17.9% |
| Q3 FY2023 | Sep 30, 2023 | $282.00M | – |
| Q2 FY2023 | Jun 30, 2023 | $206.00M | +67.5% |
| Q1 FY2023 | Mar 31, 2023 | $154.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $475.00M | +1879.2% |
| Q3 FY2022 | Sep 30, 2022 | -$1.26B | -323.9% |
| Q2 FY2022 | Jun 30, 2022 | $123.00M | -68.9% |
| Q1 FY2022 | Mar 31, 2022 | -$63.00M | -114.2% |
| Q4 FY2021 | Dec 31, 2021 | $24.00M | -93.9% |
| Q3 FY2021 | Sep 30, 2021 | $564.00M | +120.3% |
| Q2 FY2021 | Jun 30, 2021 | $395.00M | +97.5% |
| Q1 FY2021 | Mar 31, 2021 | $443.00M | +69.7% |
| Q4 FY2020 | Dec 31, 2020 | $394.00M | +68.4% |
| Q3 FY2020 | Sep 30, 2020 | $256.00M | -50.3% |
| Q2 FY2020 | Jun 30, 2020 | $200.00M | -41.0% |
| Q1 FY2020 | Mar 31, 2020 | $261.00M | -36.8% |
| Q4 FY2019 | Dec 31, 2019 | $234.00M | -26.6% |
| Q3 FY2019 | Sep 30, 2019 | $515.00M | -1.3% |
| Q2 FY2019 | Jun 30, 2019 | $339.00M | +52.7% |
| Q1 FY2019 | Mar 31, 2019 | $413.00M | -5.7% |
| Q4 FY2018 | Dec 31, 2018 | $319.00M | -44.8% |
| Q3 FY2018 | Sep 30, 2018 | $522.00M | +6.5% |
| Q2 FY2018 | Jun 30, 2018 | $222.00M | -17.2% |
| Q1 FY2018 | Mar 31, 2018 | $438.00M | -54.1% |
| Q4 FY2017 | Dec 31, 2017 | $578.00M | +12.9% |
| Q3 FY2017 | Sep 30, 2017 | $490.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $268.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $954.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $512.00M | – |
See a number that looks wrong?